This conference is for those that wish to understand both the promise of adaptive trials and the required caution.
Distinguished Faculty Includes:
Professor Andy Grieve, Senior Vice President, Clinical Trial Methodology, Aptiv Solutions
Roger Lewis, MD, Ph.D., Professor of Emergency Medicine Harbor-UCLA Medical Center Senior Medical Scientist, Berry Consultants, LLC
Kenneth Getz, Senior Research Fellow, Director of Sponsored Programs, Tufts CSDD Chairman, CISCRP
Don Berry, Ph.D., Professor of Biostatistics, University of Texas MD Anderson Cancer Center; Founder and Senior Statistical Scientist, Berry Consultants, LLC
Scott Berry, Ph.D., President & Senior Statistical Scientist, Berry Consultants, LLC
Tom Parke, Head, Clinical Trial Solutions, Tessella
Vlad Dragalin, Ph.D., Senior Vice President, Innovation Center, Aptiv Solutions
Brenda L. Gaydos, Ph.D., Research Fellow & Head, Clinical Trial Optimization, Eli Lilly
Mike Krams, M.D., Vice President & Head, Neurology Franchise, Johnson & Johnson
Steve Arlington, Ph.D., Global Advisory Leader, Pharmaceuticals and Life Sciences, PwC
Scott Gottlieb, Research Fellow, American Enterprise Institute
Who Should Attend:
CEOs, CMOs, CSOs
R&D Decision Makers in Drug Development
Therapy Area Heads
Medical Experts
Product Portfolio Managers
Senior Clinical Operations Managers
Senior Biostatisticians
Pharmacologists
Regulatory Affairs Managers
To register and for event details, visit http://www.InnovationsInClinicalTrials.com.
This event is being produced by Aptiv Solutions (aptivsolutions.com)
Media Contact:
Nicole Proulx
Cambridge Healthtech Institute
781-972-5417
nproulx@healthtech.com
Photo:
http://www.prlog.org/



